BASTA Study on STI in HIV Infected Patients
HIV Infection
About this trial
This is an interventional treatment trial for HIV Infection focused on measuring CD4-guided STI, Keywords:, HAART, Clinical outcome, Resistance, Costs, Prognostic factors, pulse therapy, treatment experienced, treatment interruption
Eligibility Criteria
Inclusion Criteria: i. Age > 17 years ii. Informed consent signed iii. Effective ongoing treatment (HIV-RNA < 50 copies/ml). Treatment must be based on any triple drug therapy. Patients must be on the same steady therapy for at least 3 months. iv. Current CD4 cell count above 800 cells/L Exclusion Criteria: i. Childbearing or breastfeeding. Women of childbearing potential will be asked to adopt effective contraceptive methods or behaviors ii. Any ongoing grade 4 (WHO) AE or laboratory abnormality with the exclusion of cholesterol, triglycerides for which a grade 3 (AHA) level will be considered an exclusion criteria. iii. Previous use of immunomodulatory agents
Sites / Locations
- Antiviral Therapy Unit, Ospedali Riuniti